KALA BIO Inc
F:27F0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
KALA BIO Inc
F:27F0
|
US |
|
B
|
Basler AG
XMUN:BSL
|
DE |
|
Carel Industries SpA
F:CIG
|
IT |
|
E
|
Evgen Pharma PLC
F:8EV
|
UK |
Shareholder Yield
Current shareholder yield for 27F0 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
27F0 Price
KALA BIO Inc
| Average Annual Return | -43.64% |
| Standard Deviation of Annual Returns | 45.64% |
| Max Drawdown | -100% |
| Market Capitalization | 550.2k EUR |
| Shares Outstanding | 4 598 420 |
| Percentage of Shares Shorted |
N/A
|
27F0 Return Decomposition
Main factors of price return
Stock Splits
27F0's latest stock split occurred on May 11, 2026
The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.
Before the split, 27F0 traded at 0.068 per share. Afterward, the share price was about 3.4.
The adjusted shares began trading on May 11, 2026. This was stock split number 2 in 27F0's history, following the previous one in Oct 21, 2022.
